AIP
BIVV

Ameritas Investment Partners’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Ameritas Investment Partners’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-32,367
Closed -$1.75M – 2985
2017
Q4 		$1.75M Sell
32,367
-12,200
-27% -$668K 0.08% 302
2017
Q3 		$2.53M Hold
44,567
– – 0.12% 184
2017
Q2 		$2.68M Buy
44,567
+439
+1% +$25K 0.13% 160
2017
Q1 		$2.4M Buy
+44,128
New +$2.17M 0.12% 185

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Ameritas Investment Partners's BIVV Position: Q1 2018 in Review

Ameritas Investment Partners sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 32,367 shares — an estimated $1.75M sold.

Ameritas Investment Partners first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $2.68M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Ameritas Investment Partners reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Ameritas Investment Partners sold 32,367 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1.75M.
  • Ameritas Investment Partners first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Ameritas Investment Partners's Bioverativ Inc. Common Stock position peaked at $2.68M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Ameritas Investment Partners's 13F filing for Q1 2018, filed 15 May 2018.